Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Immunocore Holdings (IMCR) Times Interest Earned (2021 - 2025)

Historic Times Interest Earned for Immunocore Holdings (IMCR) over the last 5 years, with Q3 2025 value amounting to -$2.36.

  • Immunocore Holdings' Times Interest Earned fell 1890.88% to -$2.36 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.79, marking a year-over-year increase of 4617.53%. This contributed to the annual value of -$3.74 for FY2024, which is 6769.15% up from last year.
  • Immunocore Holdings' Times Interest Earned amounted to -$2.36 in Q3 2025, which was down 1890.88% from -$4.89 recorded in Q2 2025.
  • Immunocore Holdings' 5-year Times Interest Earned high stood at $28.06 for Q4 2021, and its period low was -$13.03 during Q4 2023.
  • Its 5-year average for Times Interest Earned is -$0.05, with a median of -$2.94 in 2022.
  • Its Times Interest Earned has fluctuated over the past 5 years, first crashed by 31871.08% in 2023, then skyrocketed by 8538.39% in 2025.
  • Over the past 5 years, Immunocore Holdings' Times Interest Earned (Quarter) stood at $28.06 in 2021, then tumbled by 111.09% to -$3.11 in 2022, then tumbled by 318.71% to -$13.03 in 2023, then surged by 78.78% to -$2.76 in 2024, then increased by 14.74% to -$2.36 in 2025.
  • Its Times Interest Earned was -$2.36 in Q3 2025, compared to -$4.89 in Q2 2025 and -$1.2 in Q1 2025.